Abstract
Introduction
Poor adherence to recommended vitamin and mineral supplementation after bariatric surgery is common and challenging for healthcare professionals to identify. There are several questionnaires for self-reporting of adherence to chronic medication, but none has so far been evaluated for assessment of adherence to vitamin and mineral supplementation after bariatric surgery. The aim of this study was to assess the accuracy of the 5-item Medication Adherence Report Scale (MARS-5) in measuring adherence to vitamin and mineral supplementation post bariatric surgery (gastric bypass or sleeve gastrectomy).
Method
The psychometric properties of MARS-5 for vitamin and mineral supplementation were validated in two cohorts: one at 1 year post bariatric surgery (n = 120) and the other at 2 years post-surgery (n = 211). MARS-5 was compared to pharmacy refill data for vitamin B12 and combined calcium/vitamin D as reference.
Results
Correlation analyses demonstrated that the MARS-5 had acceptable validity compared to objectively measured adherence rates from pharmacy refill data (calculated as continuous, multiple-interval measures of medication availability/gaps-coefficient ranged from 0.49 to 0.54). Internal reliability (Cronbach’s α) was high: 0.81 and 0.95, respectively. There was a clear ceiling effect where one out of three had a maximum score on MARS-5.
Conclusion
MARS-5 demonstrated acceptable psychometric properties for assessment of adherence to vitamin and mineral supplementation post bariatric surgery.
Graphical Abstract
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Background
Bariatric surgery provides long-term weight loss and substantial health gains with a low rate of short-term complications [1, 2]. However, bariatric procedures are associated with long-term risks related to micronutrient deficiencies, such as neuropathy, anemia, and osteoporosis [3,4,5]. Micronutrient deficiencies are caused by impaired absorption of vitamins and minerals due to the anatomical reconstruction and physiological changes in the gastro-intestinal tract [6]. Lifelong vitamin and mineral supplementation is therefore recommended to prevent development of deficiencies after bariatric surgery [7, 8].
Previous research has shown that 10% of patients discontinue the intended lifelong vitamin and mineral supplementation within the first years after surgery [9,10,11]. Reasons for poor adherence to vitamin and mineral supplementation are complex but include forgetfulness, experience of side-effects, discomfort with taking or problems with swallowing tablets, financial constraints, and doubts about the need of supplements [10,11,12,13].
It is a challenge for healthcare providers to accurately identify patients with poor adherence [14]. To simply ask the patients if they take their supplements is not a reliable method, as patients often overreport adherence due to the social desirability of high adherence [15]. Questions about adherence to medications should be addressed in a non-judgmental way to facilitate accurate reporting [15].
There are several ways to objectively measure adherence to medication such as electronic monitoring, measuring drug concentration in blood or urine, using smart pills, or assessing prescription refill rates [16]. However, in clinical practice, these methods are expensive and time consuming [15]. An inexpensive and easy-to-use alternative way to measure adherence in the clinic is patient questionnaires. Questionnaires on adherence to medication have been designed to reduce the bias of underreporting of poor adherence [14, 16], but to the best of our knowledge, none of these has been evaluated for assessing adherence to vitamin and mineral supplementation after bariatric surgery.
The 5-item Medication Adherence Report Scale (MARS-5) is a widely used instrument for self-reported adherence to medication that has been tested for various pharmaceutical treatments [17]. MARS-5 assesses non-adherence behaviour in a non-threatening and non-judgmental way and has been translated into several languages [18,19,20,21,22]. Existing validations on the accuracy of MARS-5 for different medications cannot be generalized as valid for vitamin and mineral supplementation, as adherence behaviours to vitamin and mineral supplementation may differ from adherence behaviours to pharmaceutical treatment [23].
The aim of this study was to assess the psychometric accuracy of the MARS-5 in measuring adherence to vitamin and mineral supplementation after bariatric surgery.
Methods
Study Population
Data in this study was collected from two separate surveys, which have been described in detail elsewhere [9, 24, 25]. The study cohorts include adults undergoing bariatric surgery in the treatment of severe obesity at Vrinnevi Hospital, Norrköping, Sweden. The study participants were consecutively enrolled at routine clinic visits, between May 2017 and January 2019. The bariatric surgical techniques used were laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy. Exclusion criteria were age ≤18 years and/or inability to read or understand Swedish.
The MARS-5 Item Questionnaire
The MARS-5 questionnaire consists of five questions on forgetting, changing dosage, stopping, skipping, and taking less medication (Table 3). The score ranges from 5 to 25, where a higher MARS-5 score indicates higher self-reported adherence. One item assesses unintentional non-adherence and four items assess intentional non-adherence. The Swedish translation of MARS-5 has previously been validated for treatment with mood stabilizing medications in bipolar disorder [26].
The study participants completed the MARS-5 questionnaires at the 1-year follow-up visit post-surgery (cohort 1) or got the MARS-5 sent home by letter, with a stamped reply envelope, 2 years post-surgery (cohort 2). A total sample size of 300 participants was deemed sufficient according to recommendations by Comarey and Lee [27], which is also in line with the recommendations of having at least 20 subjects per scale item [28]. Incompletely filled MARS-5 questionnaires were handled as missing data.
Vitamin and Mineral Supplementation
All patients, regardless of surgical technique, were prescribed a daily lifelong supplementation with combined calcium-vitamin D 500mg/800 IE, and 1 mg vitamin B12. At the time of the study, iron was prescribed only to menstruating women and patients with preoperative anemia. Additionally, patients were recommended a daily over-the-counter (OTC) multivitamin tablet.
Reliability
To evaluate reliability, the internal consistency of MARS-5 was determined. Internal consistency estimates the extent to which items within a scale assess a single construct and is assessed by computing a Cronbach’s α coefficient. Values above 0.70 are considered to indicate good internal consistency [23].
Validity
Criterion-related validity refers to the degree of agreement between scores on a questionnaire and some independent criterion. The validity was evaluated by comparing the scores of MARS-5 with pharmacy refill data, which is a well-established objective adherence measurement. We examined the relationship between MARS-5 and pharmacy refill rates using the Spearman correlation coefficient.
We used pharmacy refill data from the Swedish Prescribed Drug Register, a national register containing all data on prescription refills (dosage, quantity, and date of drug refill) dispensed at pharmacies in Sweden [29]. Adherence rates were calculated for calcium/vitamin D and vitamin B12 as continuous, multiple-interval measures of medication availability/gaps (CMA). CMA is defined as the proportion of days covered by a medication during the observation period (40, 41). As the routine prophylactic supplementation after bariatric surgery is unlikely to require total adherence to achieve treatment goals [7], poor adherence was therefore defined as CMA< 50% in this study. Adherence calculations were performed using the AdhereR package, RStudio version 1.1.463 (RStudio Inc., Boston, MA), CMA version 7 [30].
The study participants were also asked if they used non-prescribed complete supplementation designed for patients after bariatric surgery, containing all micronutrients recommended in the Nordic guidelines [3]. Patients reporting use of non-prescribed supplements were excluded from the correlation analysis due to the lack of pharmacy refill data.
Sensitivity and Specificity
To assess sensitivity and specificity, the MARS-5 sum score was dichotomized into either “adherent” or “non-adherent” using a threshold of < 24 and compared with dichotomized pharmacy refill data as reference. CMA ≤ 50% to either or both vitamin B12 and combined calcium/vitamin D was considered non-adherent. Detection of non-adherence was defined as the positive outcome in the calculations of sensitivity and specificity.
Floor and Ceiling Effects
Floor and ceiling effects were assessed for MARS-5. A floor or ceiling effect means that >15% of patients receive the instrument’s highest or lowest value [22].
Ethical Approval
The study was approved by the Swedish Ethical Review Authority (2016/1259-31/4; 2017/1406-32; 2017/2101-32; 2017/117-31). All procedures were in accordance with the ethical standards of the Swedish Ethical Review Authority and the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
Results
Patient Characteristics
Patient characteristics of the two study cohorts are presented in Table 1. Of 402 patients enrolled in the two cohorts, 321 patients (80%) completed MARS-5 and were included in the current study. There was a significant difference in completion rates of MARS-5 between patients with high and low adherence to vitamin and mineral supplementation, measured with pharmacy refill data. In the group with an adherence-rate ≤ 50% to both vitamin B12 and combined calcium/vitamin D, 36% did not complete MARS-5 compared to 11% in the group with ≥ 80% adherence to both supplements (p < 0.001). There were no statistically significant differences in baseline characteristics between study participants that completed MARS-5 and those who did not.
Reliability
The MARS-5 demonstrated high internal consistency, with Cronbach’s α coefficients of 0.95 for cohort 1 (n = 120) and 0.81 for cohort 2 (n = 211) (Table 2).
Validity
There was a moderate, significant correlation between the MARS-5 scores and adherence measured with pharmacy refill data (CMA) for vitamin B12 (cohort 1: r = 0.53, p < 0.001 and cohort 2: r = 0.49, p < 0.001) and combined calcium/vitamin D (cohort 1: r = 0.50, p < 0.001 and cohort 2: r = 0.54, p < 0.001) (Table 2). Ten percent (31/321) of the study participants were excluded from correlation analysis due to use of non-prescribed complete supplementation, which is not registered in the Swedish pharmacy refill database.
Adherence Rates
When adherence was measured with pharmacy refill data, 12% of participants had poor adherence (<50% CMA) to both supplements, while 20% had poor adherence (<50% CMA) to either vitamin B12 or combined calcium/vitamin D but acceptable or high adherence to the other supplement. When adherence was measured with MARS-5 with a cutoff score for poor adherence < 24 in MARS-5, 19% were identified as having poor adherence.
Sensitivity and Specificity
When using a threshold of < 24, the MARS-5 had a sensitivity of 63% and a specificity of 82% in detecting patients with poor adherence to at least one supplement. In MARS-5, the patient is asked about “my vitamins and minerals”, i.e. not each prescribed vitamin and mineral individually. There was a large variability in the MARS-5 score in the group with poor adherence to only one of the prescribed supplements, and therefore an additional analysis was conducted where individuals with poor adherence to only one of the supplements were excluded. In the additional analysis, the MARS-5 had a sensitivity of 72% and a specificity of 82%.
Distribution of Results
The MARS-5 total score is presented in Fig. 1, where a clear ceiling effect can be seen. Mean scores of MARS-5 and its individual items are presented in Table 3.
Discussion
To identify poor adherence to vitamin and mineral supplementation after bariatric surgery is crucial for the prevention of complications related to biochemical deficiencies, as about one in five have poor adherence to the supplements. However, detecting patients with poor adherence is challenging in clinical practice. To our knowledge, this study is the first to evaluate a patient questionnaire to assess adherence to vitamin and mineral supplementation after bariatric surgery. The study demonstrates acceptable psychometric properties of MARS-5, suggesting MARS-5 as an easily accessible, inexpensive method for assessing adherence to vitamin and mineral supplementation in clinical follow-up after bariatric surgery.
MARS-5 performed well on the test of reliability, showing good internal consistency with high Cronbach’s α which confirms results from previous validations of the MARS-5 for medical treatment of other conditions [17, 18, 22, 26].
In the evaluation of validity of MARS-5 for vitamin and mineral supplementation, MARS-5 was moderately correlated with pharmacy refill data (CMA). Since there is no gold standard, different methods for measuring adherence can be chosen as reference to determine the validity of an adherence questionnaire [15]. Pharmacy refill data is advantageous because it is an objective measurement of medication availability, although it does not tell whether the patient has actually taken the medication [16]. A methodological challenge that may weaken the correlation is that MARS-5 captures more recent medication-taking behaviour while pharmacy refill is a composite measure that averages adherence over time, which in this study is a year [16]. Results show a moderate correlation between MARS-5 and CMA data which is as expected given these limitations.
The ceiling effect makes it challenging to use the MARS-5 to differentiate between degrees of adherence in groups of patients with high adherence rates. This would need to be considered if MARS-5 is to be used when researching adherence to vitamin and mineral supplementation. In a clinical follow-up setting, the ceiling effect is of less importance as the target is to identify patients with poor adherence.
A not completed MARS-5 questionnaire may indicate risk of poor adherence as do low MARS-5 scores, as people with poor adherence measured with pharmacy refill data were less likely to complete the MARS-5 questionnaire.
From a clinical perspective, MARS-5 shows suboptimal sensitivity in identifying patients with poor adherence to vitamin and mineral supplementation. The absence of a gold standard for adherence measurement makes it difficult to set a cutoff for what is an acceptable sensitivity [31, 32]. The sensitivity is in line with results from other studies validating both MARS-5 and other adherence questionnaires, using pharmacy refill data as reference [14, 32, 33]. We found that MARS-5 exhibited higher sensitivity in identifying patients who have poor adherence to all vitamins and minerals, compared to patients who only have poor adherence to either vitamin B12 or combined calcium/vitamin D and acceptable or high adherence to the other supplement. A probable explanation is that the questions in the MARS-5 questionnaire refer to multiple treatments (“my vitamin and mineral supplements”) whereas the pharmacy refill data measures adherence to vitamin B12 and adherence to calcium/vitamin D separately.
It would be of value to find tools for screening of adherence with greater possibilities of identifying patients with poor adherence to vitamin and mineral supplementation than MARS-5 provides. To combine different methods in assessing adherence may improve measurement accuracy [16]. Future studies need to focus on assessing a multi method approach, possibly combining MARS-5 and routinely collected blood samples on micronutrient status.
Even though the questionnaire does not exhibit optimal sensitivity in identifying patients with poor adherence, other psychometric properties were adequate, and we suggest MARS-5 to be used in clinical follow-up after bariatric surgery. Using MARS-5 in clinical practice improves care by highlighting the important issue of adherence, and identifying those who may be at need of further support, and providing understanding of whether non-adherence may be intentional or unintentional. As seen in previous research, factors affecting adherence to vitamin and mineral supplements are complex [10,11,12,13]. Identifying individual barriers and whether the barriers are intentional or unintentional is necessary to be able to support individual patients to improve adherence [15].
A limitation of this study is the limited sample size, and the single-site study concept influences the generalizability of the psychometric evaluation of the MARS-5 questionnaire. However, the operating center provides bariatric surgery for an entire healthcare region including both rural and urban areas. Furthermore, the study population is comparable to the national Swedish bariatric population operated at the time of the study [31].
Conclusion
Identifying poor adherence to vitamin and mineral supplementation in patients after bariatric surgery is important in order to prevent long-term complications related to micronutrient deficiencies. This study demonstrates that the MARS-5 is a potentially useful tool with good reliability and acceptable validity in assessing adherence to vitamins and minerals in patients having undergone bariatric surgery.
References
Syn NL, Cummings DE, et al. Association of metabolic-bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants. Lancet. 2021;397(10287):1830–41.
Stenberg E, Szabo E, Agren G, et al. Early complications after laparoscopic gastric bypass surgery: results from the Scandinavian Obesity Surgery Registry. Ann Surg. 2014;260(6):1040–7.
Johansson K, Svensson PA, Söderling J, et al. Long-term risk of anaemia after bariatric surgery: results from the Swedish Obese Subjects study. Lancet Diabetes Endocrinol. 2021;9(8):515–24.
Karefylakis C, Näslund I, Edholm D, et al. Prevalence of anemia and related deficiencies 10 years after gastric bypass--a retrospective study. Obes Surg. 2015;25(6):1019–23.
Paccou J, Tsourdi E, Meier C, et al. Bariatric surgery and skeletal health: a narrative review and position statement for management by the European Calcified Tissue Society (ECTS). Bone. 2022;154:116236.
Mohapatra S, Gangadharan K, Pitchumoni CS. Malnutrition in obesity before and after bariatric surgery. Dis Mon. 2020;66(2):100866.
Parrott J, Frank L, Rabena R, et al. American Society for Metabolic and Bariatric Surgery integrated health nutritional guidelines for the surgical weight loss patient 2016 update: micronutrients. Surg Obes Relat Dis. 2017;13(5):727–41.
O'Kane M, Parretti HM, Pinkney J, et al. British Obesity and Metabolic Surgery Society Guidelines on perioperative and postoperative biochemical monitoring and micronutrient replacement for patients undergoing bariatric surgery-2020 update. Obes Rev. 2020;21(11):e13087.
Spetz K, Svedjeholm S, Roos S, et al. Adherence to vitamin and mineral supplementation after bariatric surgery - a two-year cohort study. Obes Res Clin Pract. 2022;
Modi AC, Zeller MH, Xanthakos SA, et al. Adherence to vitamin supplementation following adolescent bariatric surgery. Obesity. 2013;21(3):E190–5.
Schiavo L, Scalera G, Pilone V, et al. Patient adherence in following a prescribed diet and micronutrient supplements after laparoscopic sleeve gastrectomy: our experience during 1 year of follow-up. J Hum Nutr Diet. 2017;30(1):98–104.
Smelt HJM, Heusschen L, Theel W, et al. Factors affecting patient adherence to multivitamin intake after bariatric surgery: a multicentre survey study from the patient’s perspective. Obes Surg. 2021;31(10):4316–26.
Mahawar KK, Clare K, O’Kane M, et al. Patient perspectives on adherence with micronutrient supplementation after bariatric surgery. Obes Surg. 2019;29(5):1551–6.
Stirratt MJ, Dunbar-Jacob J, Crane HM, et al. Self-report measures of medication adherence behavior: recommendations on optimal use. Transl Behav Med. 2015;5(4):470–82.
Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–97.
Stewart SF, Moon Z, Horne R. Medication nonadherence: health impact, prevalence, correlates and interventions. Psychol Health. 2022:1–40.
Chan AHY, Horne R, Hankins M, et al. The Medication Adherence Report Scale: a measurement tool for eliciting patients’ reports of nonadherence. Br J Clin Pharmacol. 2020;86(7):1281–8.
Mahler C, Hermann K, Horne R, et al. Assessing reported adherence to pharmacological treatment recommendations. Translation and evaluation of the Medication Adherence Report Scale (MARS) in Germany. J Eval Clin Pract. 2010;16(3):574–9.
Fialko L, Garety PA, Kuipers E, et al. A large-scale validation study of the Medication Adherence Rating Scale (MARS). Schizophr Res. 2008;100(1-3):53–9.
Sampaio R, Azevedo LF, Dias CC, et al. Portuguese version of the Medication Adherence Report Scale (MARS-9): validation in a population of chronic pain patients. J Eval Clin Pract. 2019;25(2):346–52.
Maria Lia Scribano FC, Michielan A, Contablo A, et al. Translation and initial validation of the Medication Adherence Report Scale (MARS) in Italian patients with Crohn’s disease. Dig Liver Dis. 2019;51(5):640–7.
Al-Qerem W, Al Bawab AQ, Abusara O, et al. Validation of the Arabic version of medication adherence report scale questionnaire and beliefs about medication -specific questionnaire: a factor analysis study. PLoS One. 2022;17(4):e0266606.
Lin CY, Chen H, Pakpour AH. Correlation between adherence to antiepileptic drugs and quality of life in patients with epilepsy: a longitudinal study. Epilepsy Behav. 2016;63:103–8.
Bonn SE, Hult M, Spetz K, et al. App technology to support physical activity and intake of vitamins and minerals after bariatric surgery (the PromMera Study): protocol of a randomized controlled clinical trial. JMIR Res Protoc. 2020;9(8):e19624.
Spetz K, Hult M, Olbers T, et al. A smartphone application to improve adherence to vitamin and mineral supplementation after bariatric surgery. Obesity. 2022;
Bäck A, Sundell KA, Horne R, et al. The Medication Adherence Report Scale (MARS-5) in a Swedish sample with bipolar disorder - a pilot study. Int J Pers Cent Med. 2012;2:263–70.
Comrey AL, Lee HB, et al. A first course in factor analysis: Psychology Press; 1992.
Anthoine E, Moret L, Regnault A, et al. Sample size used to validate a scale: a review of publications on newly-developed patient reported outcomes measures. Health Qual Life Out. 2014;12:176.
The Swedish National Board of Health and Welfare. The Swedish National Prescribed Drug Register 2022, February 08 [updated 2022-01-14. Available from: https://www.socialstyrelsen.se/en/statistics-and-data/registers/register-information/national-prescribed-drug-register/.
Dima AL, Dediu D. Computation of adherence to medication and visualization of medication histories in R with AdhereR: towards transparent and reproducible use of electronic healthcare data. PLoS One. 2017;12(4):e0174426.
Scandinavian Obesity Surgery Registry. Årsrapport SOReg 2022 Del 1 – Operationsstatistik, Och Tidiga Komplikationer (Annual Report SOReg 2022 Part 1– Surgery Statistics, and Early Complications) [report in Swedish]. Scandinavian Obesity Surgery Registry (SOReg); 2023
Moon SJ, Lee WY, Hwang JS, et al. Accuracy of a screening tool for medication adherence: a systematic review and meta-analysis of the Morisky Medication Adherence Scale-8. PLoS One. 2017;12(11):e0187139.
Tommelein E, Mehuys E, Van Tongelen I, et al. Accuracy of the Medication Adherence Report Scale (MARS-5) as a quantitative measure of adherence to inhalation medication in patients with COPD. Ann Pharmacother. 2014;48(5):589–95.
Acknowledgements
The authors would like to thank the staff at Vrinnevi Hospital involved in this study and the study team round the PromMera study at Karolinska Institutet for their work and kind support.
Funding
Open access funding provided by Linköping University. This study was funded by grants from the County Council of Östergötland and Medical Research Council of Southeast Sweden.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical Approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the Swedish Ethical Review Authority (2016/1259-31/4; 2017/1406-32; 2017/2101-32; 2017/117-31). Informed consent was obtained from all individual participants included in the study.
Conflict of Interest
Torsten Olbers has received reimbursement unrelated to the submitted article from Johnson & Johnson (advisory board, educational activities, lecturer), NovoNordisk (advisory board, educational activities), Merck (lecturer), and Mölnlycke (lecturer). All reimbursement directed to his institution.
Zoe Moon has undertaken paid work for UCL-Business company Spoonful of Sugar Ltd.
Rob Horne is supported by the National Institute for Health Research (NIHR), Collaboration for Leadership in Applied Health Research and Care (CLAHRC), and North Thames at Bart’s Health NHS Trust and Asthma UK (AUKCAR). He reports speaker engagements with honoraria from AbbVie, Abbott, Amgen, Astellas, AstraZeneca, bioMérieux, Boehringer Ingelheim, Biogen, Gilead Sciences, GlaxoSmithKline, Janssen, Merck Sharp Dohme, Merck, Novartis, Pfizer, Procter & Gamble, Roche, Sanofi, Shire Pharmaceuticals, TEVA, and UCB and personal consultancy with Amgen, Abbott, AstraZeneca, and Novartis. He is Founding Director of a UCL-Business company (Spoonful of Sugar Ltd) providing consultancy on treatment engagement and patient support programmes to healthcare policy makers, providers, and pharmaceutical industry.
All other authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Key Points
• Poor adherence to supplementation after bariatric surgery is common and hard to identify.
• This is the first study to evaluate a patient questionnaire to assess adherence to supplementation after bariatric surgery.
• The MARS-5 has acceptable psychometric properties for assessment of adherence to supplementation.
• MARS-5 may be a useful tool to identify poor adherence in clinic.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Spetz, K., Olbers, T., Östbring, M. et al. Using the 5-Item Medication Adherence Report Scale (MARS-5) to Screen for Non-adherence to Vitamin and Mineral Supplementation After Bariatric Surgery. OBES SURG 34, 576–582 (2024). https://doi.org/10.1007/s11695-023-07027-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-023-07027-x